SCHEMBL7712404

SCHEMBL7712404

Nc1ncc(Oc2ccccc2Cl)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.44
DRD2 P14416 2/20 0.43
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 2/20 0.43
DRD3 P35462 1/20 0.43
HTR1A P08908 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
HTT P42858 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
AKT1 P31749 1/20 0.40
PIK3CA P42336 1/20 0.40
MTOR P42345 1/20 0.40
TSHR P16473 1/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
HRH1 P35367 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7716686 0.88 HTR3E (0.42) METAP1DRD2ROCK2ROCK1DRD3
SCHEMBL7708465 0.87 HTR7 (0.43) METAP1DRD2ROCK2ROCK1HTR1A
SCHEMBL7708454 0.87 ROCK2 (0.43) METAP1DRD2ROCK2ROCK1HTR1A
SCHEMBL7712423 0.87 HTR2A (0.44) METAP1DRD2ROCK2ROCK1HTR1A
SCHEMBL7708442 0.83 LMNA (0.45) METAP1ROCK2ROCK1HTTKDM4E
SCHEMBL7714281 0.83 HTR3E (0.44) DRD2ROCK2ROCK1HTR1AHTR7
SCHEMBL7716574 0.82 KMT2A (0.53) METAP1DRD2ROCK2ROCK1DRD3
SCHEMBL8133641 0.82 HTR3E (0.38) DRD2ROCK2ROCK1HTR1AHTR7
SCHEMBL7714141 0.81 SCN9A (0.47) DRD2ROCK2ROCK1DRD3HTR1A
SCHEMBL7708476 0.81 ROCK2 (0.40) METAP1DRD2ROCK2ROCK1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed